title: Risk of port-site metastases in pelvic cancers after robotic surgery.
abstract: OBJECTIVE
  To assess the risk of occurrence of port-site metastases after robotic surgery for pelvic cancer.
  
  
  METHODS
  Retrospective study from June 2007 to March 2013 of patients with gynecologic cancer who underwent robot-assisted surgery. We collected preoperative data, including characteristics of patients and FIGO stage, intraoperative data (surgery performed, number of ports), and postoperative data (occurrence of metastases, occurrence of port-site metastases).
  
  
  RESULTS
  115 patients were included in the study: 61 with endometrial cancer, 50 with cervical cancer and 4 with ovarian cancer. The surgical procedures performed were: hysterectomy with bilateral salpingo-oophorectomy, radical hysterectomy, pelvic lymphadenectomy, para-aortic lymphadenectomy and omentectomy. All surgical procedures required the introduction of 4 ports, 3 for the robot and 1 for the assistant. With a mean follow-up of 504.4 days (507.7 days for endometrial cancer, 479.5 days for cervical cancer, and 511.3 for ovarian cancer), we observed 9 recurrences but no port-site metastasis.
  
  
  CONCLUSIONS
  No port-site metastasis has occurred in our series. However, larger, prospective and randomized works are needed to formally conclude.
authors.affiliation: Hôpital Européen Georges-Pompidou, Service de Chirurgie Gynécologique et Cancérologique and Faculté de Médecine, Université Paris-Descartes, France. Electronic address: serorjulien@gmail.com.
authors.forename: J
authors.initials: J
authors.lastname: Seror
authors.affiliation: Hôpital Européen Georges-Pompidou, Service de Chirurgie Gynécologique et Cancérologique and Faculté de Médecine, Université Paris-Descartes, France.
authors.forename: A-S
authors.initials: AS
authors.lastname: Bats
authors.affiliation: Hôpital Européen Georges-Pompidou, Service de Chirurgie Gynécologique et Cancérologique and Faculté de Médecine, Université Paris-Descartes, France.
authors.forename: C
authors.initials: C
authors.lastname: Bensaïd
authors.affiliation: Hôpital Européen Georges-Pompidou, Service de Chirurgie Gynécologique et Cancérologique and Faculté de Médecine, Université Paris-Descartes, France.
authors.forename: N
authors.initials: N
authors.lastname: Douay-Hauser
authors.affiliation: Hôpital Européen Georges-Pompidou, Service de Chirurgie Gynécologique et Cancérologique and Faculté de Médecine, Université Paris-Descartes, France.
authors.forename: C
authors.initials: C
authors.lastname: Ngo
authors.affiliation: Hôpital Européen Georges-Pompidou, Service de Chirurgie Gynécologique et Cancérologique and Faculté de Médecine, Université Paris-Descartes, France.
authors.forename: F
authors.initials: F
authors.lastname: Lécuru
mesh_terms: D034861:Abdominal Wall; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001011:Aorta; D016889:Endometrial Neoplasms / Q000473:pathology / Q000601:surgery*; D005260:Female; D006801:Humans; D007044:Hysterectomy / Q000009:adverse effects; D008197:Lymph Node Excision / Q000009:adverse effects; D008875:Middle Aged; D009366:Neoplasm Seeding; D010051:Ovarian Neoplasms / Q000473:pathology / Q000601:surgery*; D010052:Ovariectomy / Q000009:adverse effects; D010388:Pelvis; D012189:Retrospective Studies; D065287:Robotic Surgical Procedures / Q000009:adverse effects*; D058994:Salpingectomy / Q000009:adverse effects; D002583:Uterine Cervical Neoplasms / Q000473:pathology / Q000601:surgery*
keywords: Pelvic cancer; Port-site metastasis; Robotic surgery